Xbrane Biopharma (XBRANE.ST) Stock Price
Xbrane Biopharma Price
Revenue has compounded at 47.3% per year over the past 13 years to 152.35 M SEK. Xbrane Biopharma's net margin stands at 83.5%, up from -1,656.2% several years earlier. Analysts set a median price target of 11.22 SEK, implying 19.6% below the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
Xbrane Biopharma stock price
Xbrane Biopharma business model & stock analysis
Frequently asked questions about Xbrane Biopharma
Analysts currently set an average price target of 11.22 SEK for the Xbrane Biopharma stock (median: 11.22 SEK), implying -19.6 % versus the latest price. The consensus is based on 5 analyst ratings.
6 analysts currently rate the Xbrane Biopharma stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect Xbrane Biopharma to generate revenue of 180.00 M SEK and earnings per share of -0.09 SEK.
Converted at the current exchange rate, the Xbrane Biopharma share trades at 1.25 EUR (13.95 SEK).
The Xbrane Biopharma share (XBRANE.ST) is listed on 4 stock exchanges, including: Frankfurt (7XB.F), München (7XB.MU), Stockholm (XBRANE.ST).
The expected revenue of Xbrane Biopharma is 180.00 M SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Xbrane Biopharma is -39.97 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Xbrane Biopharma is currently -162.26. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Xbrane Biopharma stock.
The price-to-sales ratio (P/S) of Xbrane Biopharma is currently 36.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Xbrane Biopharma stock.
The Eulerpool Quality Score for Xbrane Biopharma is 4/10.
The ISIN of Xbrane Biopharma is SE0026598583. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Xbrane Biopharma is A2ADY1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Xbrane Biopharma is XBRANE.ST. The ticker symbol is used to trade Xbrane Biopharma shares on the stock exchange.
Xbrane Biopharma stock
Xbrane Biopharma Peer Group
Xbrane Biopharma Ticker
All fundamentals and in-depth analysis of Xbrane Biopharma
Our stock analysis for Xbrane Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xbrane Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.